Summary
Twelve patients with essential hypertension on no other drug treatment were entered into a randomised crossover study of 5, 10 and 20 mg capsules of nifedipine given 3 times a day and 20 mg tablets given twice a day. Each dose was given for 2 weeks in a random order. All forms of nifedipine were effective in lowering blood pressure.
However, 5 mg capsules were less effective than the 10 and 20 mg capsules or 20 mg tablets. There was little to choose between the latter. All doses of nifedipine were more effective 1 and 3 h after the dose compared to subsequent times afterwards. Indeed, as time elapsed after the last dose up to 12 h, there was a gradual increase in blood pressure. However, even at 12 h the 10, 20 mg capsules and 20 mg tablets were still causing an approximate 10% reduction in blood pressure.
Nifedipine tablets are as effective as capsules though they might be longer acting, particurarly around 6 h after the last dose.
References
Aoki K, Kondo S, Mochizuki A, Yoshida T, Kato S, Kato K, Takikawa K (1978) Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 96: 218–226
Bailey S, Dobbs RJ, Robinson BF (1982) Nifedipine in the treatment of hypertension: Report of a double blind controlled trial. Br J Clin Pharmacol 14: 509–512
Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM, Corvol P (1983) Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur J Clin Pharmacol 24: 145–150
Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA (1985) Sodium restriction lowers high blood pressure through a decreased response of the renin system. Direct evidence using saralasin. J Hypertens 3: 243–247
Guazzi M, Olivari MT, Polese A, Fiorentini C, Magrini F, Moruzzi P (1977) Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22: 528–532
Hallin L, Andren L, Hansson L (1983) Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol 5: 1083–1085
Hornung RS, Gould BA, Jones RI, Sonecha TN, Raftery EB (1983) Nifedipine tablets for systemic hypertension: A study using continuous ambulatory intra-arterial recording. Am J Cardiol 51: 1323–1327
Jakobsen P, Lederballe Pedersen O, Mikkelsen E (1979) Determination of nifedipine and one of its metabolites using electroncapture detection. J Chromatogr 162: 81–87
Landmark K (1985) Antihypertensive and metabolic effects of long-term therapy with nifedipine slow-release tablets. J Cardiovasc Pharmacol 7: 12–17
Lederballe Pedersen O, Mikkelsen E (1978) Acute and chronic effects of nifedipine in arterial hypertension. Eur J Clin Pharmacol 14: 375–381
MacGregor GA, Markandu ND, Rotellar C, Smith SJ, Sagnella GA (1983) The acute response to nifedipine is related to pretreatment blood pressure. Postgrad Med J 59 [Suppl 2]: 91–94
Marone C, Luisoli S, Bomio F, Beretta Piccoli C, Bianchetti MG, Weidmann P (1984) Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic. J Hypertens 2 [Suppl 3]: 449–452
Midtbo K, Hals O, van der Meer J (1982) Verapamil compared with nifedipine in the treatment of essential hypertension. J Cardiovasc Pharmacol 4 [Suppl 3]: 363–368
Ochs HR, Ramsch KD, Verburg-Ochs B, Greenblatt DJ, Gerloff J (1984) Nifedipine: Kinetics and dynamics after single oral doses. Klin Wochenschr 62: 427–429
Olivari MT, Bartorelli C, Polese A, Fiorentini C, Moruzzi P, Guazzi MD (1979) Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59: 1056–1062
Raemsch KD, Sommer J (1983) Pharmacokinetics and metabolism of nifedipine. Hypertension 5 [Suppl 2]: 18–24
Taburet AM, Singlas E, Colin JN, Banzet O, Thibonnier M, Corvol P (1983) Pharmacokinetic studies of nifedipine tablet — correlation with antihypertensive effects. Hypertension 5 [Suppl 2]: 29–33
Thibonnier M, Bonnet F, Corvol P (1980) Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension. Eur J Clin Pharmacol 17: 161–164
Tucker FA, Minty PSB, MacGregor GA (1985) Study of nifedipine photodecomposition in plasma and whole blood using capillary gas liquid chromatography. J Chromatogr 342: 193–198
Zar JH (1984) Biostatistical analysis (2nd edn). Prentice-Hall, Englewood Cliffs, NJ 07632
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cappuccio, F.P., Markandu, N.D., Tucker, F.A. et al. Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: A randomised crossover study. Eur J Clin Pharmacol 30, 723–725 (1986). https://doi.org/10.1007/BF00608223
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00608223